Tech Company Financing Transactions
HemCon Medical Technologies Funding Round
HemCon Medical Technologies closed a $12 million funding round on 3/19/2007. Investors included Camden Partners.
Transaction Overview
Company Name
Announced On
3/19/2007
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors
Camden Partners (Richard Berkeley)
Proceeds Purpose
The additional financing will
be used to accelerate product development activities, expand markets and to invest in capital
equipment and facilities.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
10575 Southwest Cascade Ave. 130
Portland, OR 97223
USA
Portland, OR 97223
USA
Phone
Website
Email Address
Overview
HemCon offers a variety of hemostatic solutions worldwide. HemCon is a wholly owned subsidiary of publicly traded TriStar Wellness..ticker: $TWSI
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barry Starkman
Chief Financial Officer
Nick Hart
Chief Scientific Officer
Simon McCarthy
VP - R & D
Keith Real
Browse more venture capital transactions:
Prev: 3/19/2007: NeuroPure venture capital transaction
Next: 3/20/2007: Transoma Medical venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs